Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus DNA.

MLA

Liu, Li‐Ting, et al. “Identifying Distinct Risks of Treatment Failure in Nasopharyngeal Carcinoma: Study Based on the Dynamic Changes in Peripheral Blood Lymphocytes, Monocytes, N Classification, and Plasma Epstein‐Barr Virus DNA.” Head & Neck, vol. 44, no. 1, Jan. 2022, pp. 34–45. EBSCOhost, https://doi.org/10.1002/hed.26897.

APA

Liu, L., Liang, Y., Guo, S., Xie, Y., Jia, G., Wen, D., Tang, L., Chen, Q., & Mai, H. (2022). Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus DNA. Head & Neck, 44(1), 34–45. https://doi.org/10.1002/hed.26897

Chicago

Liu, Li‐Ting, Yu‐Jing Liang, Shan‐Shan Guo, Yao Xie, Guo‐Dong Jia, Dong‐Xiang Wen, Lin‐Quan Tang, Qiu‐Yan Chen, and Hai‐Qiang Mai. 2022. “Identifying Distinct Risks of Treatment Failure in Nasopharyngeal Carcinoma: Study Based on the Dynamic Changes in Peripheral Blood Lymphocytes, Monocytes, N Classification, and Plasma Epstein‐Barr Virus DNA.” Head & Neck 44 (1): 34–45. doi:10.1002/hed.26897.